1/28/2011 11:59:05 AM
January 28, 2011 -- Tianyin Pharmaceutical completed construction of its Jiangchuan macrolide facility in the Xinjin Industrial Development Area, near Chengdu, China. The company says it expects the plant to add revenues during its 2011 fiscal year. In its Phase I state, the facility is capable of producing up to 240 tons of azithromycin API for domestic and international markets. More details....
comments powered by